BRNS vs PFG · $38.2M cap vs P/E 16, rev $15.63B
Barinthus Biotherapeutics plc (BRNS) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported PFG revenue for 2025-12-31 was $15.63B. Net income was $1.19B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
BRNS currently screens at market cap $38.2M. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the BRNS and PFG stock pages for the full models.
Not investment advice.